The Company was incorporated as ‘Chandra Bhagat Pharma Private Limited’ at Mumbai on March 10, 2003, under the provisions of the Companies Act, 1956 vide Certificate of Incorporation issued by Assistant Registrar of Companies, Maharashtra, Mumbai. Consequent upon the conversion of the Company from Private Limited Company to Public Limited Company, the name of the Company was changed to ‘Chandra Bhagat Pharma Limited’ and fresh Certificate of Incorporation consequent upon the conversion from Private Limited Company to Public Limited Company dated March 20, 2019 was issued by the Registrar of Companies, RoC- Mumbai.

Business area of the Company:

The company is engaged in the marketing of lifesaving medicines in India such as Cardiovascular, Antineoplastic, Antibiotics and Hormones medicines. It provides pharmaceuticals and special chemical products in the Indian and international market. It has wide range of products portfolio of pharmaceutical formulation including IV & IM range Injections, few tablets to cater the Domestic & Export Market.

Major Events and milestones:

• 2003: Incorporation of the company in the name of Chandra Bhagat Pharma Private Limited.
• 2015: The Company has entered into supply and distribution agreement on November 9, 2015 with Sinopharm India Private Limited (Sinopharma), a subsidiary company of China National Pharmaceutical Group for importing the vaccines known as ‘HEPATITIS A (HepA)’.
• 2017: Registration for supply of API like Urokinase (Cardiac), L-Asparaginase (Oncology), Heparin Sodium (Nephrology), and Enoxaparin Sodium (Cardiac).
• 2019: The Company got converted into Public Limited Company.